Duke Rohlen

Duke serves as CEO and Managing Director of Ajax Health. He also serves on the board of current Ajax companies Ablacon (Executive Chairman), Serpex Medical (Executive Chairman), Verix Health (Executive Chairman) and Foresight. He has over 20 years of experience as an executive in medical device companies.

Prior to Ajax, Duke co-founded and served as the Chairman and CEO of EPIX Therapeutics, which was acquired by Medtronic in 2019. Prior to EPIX, Duke served as co-founder and CEO of Spirox, which was acquired by Entellus in 2017. Prior to Spirox, he co-founded and served as CEO of CV Ingenuity, which was acquired by Covidien in 2013. Prior to CV Ingenuity, Duke served in a variety of roles at FoxHollow Technologies before being named President. In this role, Duke led the sale of the company to ev3 (now Medtronic) in 2008. Prior to FoxHollow, Duke served as an entrepreneur-in-residence at the private equity firm Alta Partners. Duke began his professional career as the co-founder and President of a 9-unit, ~$20 million per year restaurant company. Duke currently serves as a Trustee of the United States Ski and Snowboard Association.

Duke received an M.B.A. from Harvard Business School and a B.A. from Stanford University.